• 1
    Association of Directors of Anatomic and Surgical Pathology. Standardization of the surgical pathology report. Am J Surg Pathol. 1992; 16: 8486.
  • 2
    Rosai J. Standardized reporting of surgical pathology diagnoses for the major tumor types. Am J Clin Pathol. 1993; 100: 240255.
  • 3
    Hammond MH, Compton CC. Protocols for the examination of tumors of diverse sites: introduction. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 2000; 124: 1316.
  • 4
    College of American Pathologists. Guidelines for data to be included in consultation reports on breast cancer, bladder cancer, and Hodgkin's disease. Pathologist. 1986; 40: 1823.
  • 5
    Murphy WM, Crissman JD, Johansson SL, et al. Recommendations for the reporting of urinary bladder specimens containing bladder neoplasms. Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol. 1996; 106: 568570.
  • 6
    Hammond EH, Henson DE. Practice protocol for examination of specimens removed from patients with carcinoma of the urinary bladder. College of American Pathologists. Arch Pathol Lab Med. 1996; 120: 11031111.
  • 7
    ADASP Committee. ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Mod Pathol. 2001; 14: 629632.
  • 8
    Branston LK, Greening S, Newcombe RG, et al. The implementation of guidelines and computerized forms improves the completeness of cancer pathology reporting. The CROPS project: a randomized controlled trial in pathology. Eur J Cancer. 2002; 38: 764772.
  • 9
    Wilkinson NW, Shahryarinejad A, Winston JS, et al. Concordance with breast cancer pathology reporting practice guidelines. J Am Coll Surg. 2003; 196: 3843.
  • 10
    Cheng L, Weaver AL, Leibovich BC, et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer. 2000; 88: 23262232.
  • 11
    Herr HW, Bochner BH, Dalbagni G, et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002; 167: 12951298.
  • 12
    Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003; 349: 859866.
  • 13
    FlemingID, CooperJS, HensenDE, et al., editors. AJCC cancer staging manual (5th edition). Philadelphia: Lippincott-Raven, 1998.
  • 14
    Sobin LH, Greene FL. TNM classification: clarification of number of regional lymph nodes for pN0. Cancer. 2001; 92: 452453.
  • 15
    Herr HW, Bochner BH, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of nodes retrieved in cystectomy specimens. J Urol. 2002; 166: 25952596.
  • 16
    Quek ML, Stein JP, Clark PE, et al. The natural history of surgically-treated bladder cancer with extravesical extension. J Urol. 2002; 167: 306309.
  • 17
    Montie JE, Wood DP, Pontes JE, et al. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer. 1989; 63: 381385.
  • 18
    Wiley EL, Davidson P, McIntire DD, et al. Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia. Urology. 1997; 49: 692696.
  • 19
    Herr HW. Pathologic examination of radical cystectomy specimens. Cancer. 2002; 10: 668669.
  • 20
    Amin MB, Srigley JR, Grignon DJ, et al. Updated protocol for the examination of specimens from patients with carcinoma of the urinary bladder, ureter, and renal pelvis. Arch Pathol Lab Med. 2003; 127: 12631279.